Common Arthritis Drug May Reduce Response to COVID-19 Vaccine

Published on May 27, 2021

A widely used medicine for autoimmune diseases may lower people’s immune response to the Pfizer mRNA COVID-19 vaccine, a new study suggests. The drug, called methotrexate, is often given to patients with immune-mediated inflammatory conditions such as rheumatoid arthritis…

Read Full Article (External Site)